OOIR: Observatory of International Research

Papers

(The TQCC of SLAS Discovery is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Bioassay protocol metadata annotation: Proposed standards adoption	131
Protocol for 3D screening of lung cancer spheroids using natural products	47
Ex vivo discovery of synergistic drug combinations for hematologic malignancies	46
SLAS special issue editorial 2022: 3D cell culture approaches of microphysiologically relevant models	42
Fluorescent probe for the identification of potent inhibitors of the macrophage infectivity potentiator (Mip) protein of Burkholderia pseudomallei	41
Genetically encoded fluorogenic RNA-based bioluminescence resonance energy transfer (BRET) sensors for cellular imaging and target detection	36
FLECS technology for high-throughput screening of hypercontractile cellular phenotypes in fibrosis: A function-first approach to anti-fibrotic drug discovery	31
POLARISED views and FRETting about probe modulation assays: Learning from High Throughput Screening	31
Standards for reporting optical biosensor experiments (STROBE): Improving standards in the reporting of optical biosensor-based data in the literature	29
Magnetic 3D bioprinting of skeletal muscle spheroid for a spheroid-based screening assay	29
Temperature-related intensity change (TRIC)-based high throughput screening platform for the discovery of CHI3L1-targeted small molecules	24
Outline and background for the EU-OS solubility prediction challenge	24
Single-plate kinome screening in live-cells to enable highly cost-efficient kinase inhibitor profiling	24
Using measures of metabolic flux to align screening and clinical development: Avoiding pitfalls to enable translational studies	24
An efficient and scalable data analysis solution for automated electrophysiology platforms	21
HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin	19
Emerging drug discovery ecosystems	18
Role Of Vaccines Against COVID-19 Pandemic	18
Development of high-throughput lacrimal gland organoid platforms for drug discovery in dry eye disease	17
The Impact of Assay Design on Medicinal Chemistry: Case Studies	17
Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells	16
Parallel in vitro ion channel and in vivo zebrafish assaying of elapid snake venoms following chromatographic separation of toxin components	16
Nanobodies: A Game-Changer in Cell-Mediated Immunotherapy for Cancer	15
Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis	15
Drug repurposing screen for the rare disease ataxia-telangiectasia	15

FocA: A deep learning tool for reliable, near-real-time imaging focus analysis in automated cell assay pipelines	14
High-throughput screening for the identification of dual inhibitors of BRD4 and RIPK3 toward the development of small-molecule medical countermeasure agents against arsenicals	13
Label-free high-throughput screening via acoustic ejection mass spectrometry put into practice	13
Screening for molecular glues – Challenges and opportunities	13
Assay of Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2) Inhibitors	12
Development of a live cell assay for the zinc transporter ZnT8	12
Comparative analysis of antibody-mediated loss-of-function versus gene knock-out and knock-down	12
Highly scalable arrayed CRISPR mediated gene silencing in primary lung small airway epithelial cells	12
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening	12
In Memoriam	12
Screening for modulators of autism spectrum disorder using induced human neurons	11
High-throughput screening for identifying acetylcholinesterase inhibitors: Insights on novel inhibitors and the use of liver microsomes	11
Protocol to develop A 3D tumor model for drug testing applications	11
Bonferroni’s method, not Tukey’s, should be used to control the total number of false positives when making multiple pairwise comparisons in experiments with few replicates	10
Corrigendum to “Varieties of Interactions of anti-CD133 Aptamers with Cell Cultures from Patient Glioblastoma” [SLAS Discov. 2024 Nov 16;29(8):100195]	10
High-Throughput cell-based immunofluorescence assays against influenza	10
A perspective on the discovery of enzyme activators	10
Automated high-throughput, high-content 3D imaging of intact pancreatic islets	9
VOC analysis for rapid, early detection of bacteria, mold, and mycoplasma in cell and tissue cultures	9
Development and validation of a generic methyltransferase enzymatic assay based on an SAH riboswitch	9
3D-Suspension culture platform for high throughput screening of neurotoxic chemicals using LUHMES dopaminergic neurons	9
Identification of tau-tubulin kinase 1 inhibitors by microfluidics-based mobility shift assay from a kinase inhibitor library	9
A multiparametric calcium signal screening platform using iPSC-derived cortical neural spheroids.	9
Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate canc	8
Creating a more strategic small molecule biophysical hit characterization workflow	8
Complex Tumor Spheroids, a Tissue-Mimicking Tumor Model, for Drug Discovery and Precision Medicine	8
A scalable human gut-immune co-culture model for evaluating inflammatory bowel disease anti-inflammatory therapies	8
Publisher's Note	8
Deep Learning Image Analysis of High-Throughput Toxicology Assay Images	8
Phenotypic Screening Following Transcriptomic Deconvolution to Identify Transcription Factors Mediating Axon Growth Induced by a Kinase Inhibitor	8
Development of a high-throughput TR-FRET screening assay for a fast-cycling KRAS mutant	8
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies	8
SLAS Discovery – The Next Generation of Research	7
An overview of drugging the bacterial cytoskeleton, rod, and divisome systems	7
Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines	7
Identification of potent small molecule inhibitors of SARS-CoV-2 entry	7
Protocol for kinetic mode potassium channel assays on common plate readers and microscopes	7
Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders	7
In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models	7
WITHDRAWN: Digital microfluidics as an emerging tool for bacterial protocols	7
Identification of novel inflammasome inhibitors via cellular NLRP3 target engagement assays	7
Using chemical and biological data to predict drug toxicity	7
A robust CETSA data analysis automation workflow for routine screening	7
New homocysteine consumption assay for high-throughput screening of human cystathionine-β-synthase	6
Addressing Compound Reactivity and Aggregation Assay Interferences: Case Studies of Biochemical High-Throughput Screening Campaigns Benefiting from the National Institutes of Health Assay Guidance Man	6
Automation of high-throughput mRNA-seq library preparation: a robust, hands-free and time efficient methodology	6
Protocol for high throughput 3D drug screening of patient derived melanoma and renal cell carcinoma	6
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models	6
Absolute quantification of Neuron-specific enolase based on surface plasmon resonance	6
Development of a continuous assay for high throughput screening to identify inhibitors of the purine salvage pathway in Plasmodium falciparum	6

WITHDRAWN: Towards robotic laboratory automation Plug & play: Survey and concept proposal on teaching-free robot integration with the lapp digital twin